免疫缺陷患者慢性HBV感染的管理
—— 作者:王贵强 时间:2010-08-11
阅读数:
1978
简介:Lamivudine has been approved to be effective and safe in the management of immunosuppressive patients, other nucleoside analogues (telbivudine, entecavir) or nucleotide analogues (adefovir dipivoxil, tenofovir) are potential candidates in this situation, but larger experiences are yet missing.
请登录后查看详细内容
标签:
名家视点
名家视点
乙肝
发表评论
全部评论